Swedbank’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-46,307
Closed -$4.12M 703
2026
Q1
$4.12M Sell
46,307
-3,700
-7% -$380K ﹤0.01% 573
2025
Q4
$4.76M Buy
50,007
+107
+0.2% +$10.8K ﹤0.01% 572
2025
Q3
$4.92M Buy
49,900
+10,000
+25% +$1.07M 0.01% 564
2025
Q2
$4.25M Buy
39,900
+2,400
+6% +$242K ﹤0.01% 560
2025
Q1
$3.41M Buy
+37,500
New +$4.2M ﹤0.01% 579

Other funds holding BNTX

Swedbank's BNTX Position: Q2 2026 in Review

Swedbank sold out of BioNTech (BNTX) in Q2 2026, closing a stake of 46,307 shares — an estimated $4.12M sold.

Swedbank first reported a position in BNTX in Q1 2025 and held it in 5 quarters. The position peaked at $4.92M in Q3 2025. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Swedbank reported no remaining BioNTech position as of Q2 2026 after selling out during the quarter.
  • Swedbank sold 46,307 BioNTech shares in Q2 2026, an estimated $4.12M.
  • Swedbank first reported a position in BioNTech in Q1 2025 and held it in 5 quarters.
  • Swedbank's BioNTech position peaked at $4.92M in Q3 2025.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.